EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Recent developments in the delivery of peptide nucleic acids (PNAs)

Srijani Sarkar iD, Niren Murthy iD

RSC Chemical Biology · 2026 · 7 (3) · 363-375

DOI: 10.1039/d5cb00301f ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift RSC Chemical Biology, 2026. Verfasst von Srijani Sarkar und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, Innovative Genomics Institute, University of California Berkeley Berkeley CA USA nmurthy@berkeley.edu. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PNAs have strong therapeutic potential but poor cellular uptake. This graphic highlights approaches like backbone modification, transporter conjugation, and nanoparticle encapsulation that have improved delivery and enhanced antisense activity.

Autor:innen und Institutionen

  • Department of Bioengineering, Innovative Genomics Institute, University of California Berkeley Berkeley CA USA nmurthy@berkeley.edu.

ORCID-Profile: Srijani Sarkar, Niren Murthy

Zitieren

APA

Sarkar, S., & Murthy, N. (2026). Recent developments in the delivery of peptide nucleic acids (PNAs). RSC Chemical Biology, 7(3), 363-375. https://doi.org/10.1039/d5cb00301f

Vancouver

Sarkar S, Murthy N. Recent developments in the delivery of peptide nucleic acids (PNAs). RSC Chemical Biology. 2026;7(3):363-375. doi:10.1039/d5cb00301f

BibTeX
@article{Sarkar2026,
  author = {Sarkar, Srijani and Murthy, Niren},
  title = {Recent developments in the delivery of peptide nucleic acids (PNAs)},
  journal = {RSC Chemical Biology},
  year = {2026},
  volume = {7},
  number = {3},
  pages = {363--375},
  doi = {10.1039/d5cb00301f}
}
Kostenlos starten →